| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Sep 19 | A | 107 | $0.00 | — |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Mar 4 | S | 265 | $325.67 | $86K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Mar 4 | S | 345 | $324.88 | $112K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Mar 4 | S | 973 | $323.84 | $315K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Mar 4 | S | 444 | $323.01 | $143K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Mar 4 | S | 368 | $321.82 | $118K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Mar 4 | S | 274 | $320.81 | $88K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Mar 4 | S | 129 | $320.01 | $41K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Mar 4 | S | 135 | $319.03 | $43K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEODERIV | Mar 2 | A | 110,746 | $0.00 | —? |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEODERIV | Mar 2 | A | 30,425 | $0.00 | —? |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Mar 2 | S | 160 | $332.64 | $53K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Mar 2 | S | 399 | $331.93 | $132K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Mar 2 | S | 346 | $330.85 | $114K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Mar 2 | S | 722 | $329.71 | $238K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Mar 2 | S | 424 | $328.71 | $139K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Mar 2 | S | 1,399 | $327.67 | $458K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Mar 2 | S | 1,669 | $326.81 | $545K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Mar 2 | S | 1,098 | $325.63 | $358K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Mar 2 | S | 382 | $324.65 | $124K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Mar 2 | S | 200 | $323.62 | $65K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Mar 2 | A | 13,844 | $0.00 | — |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEODERIV | Feb 27 | M | 5,921 | $0.00 | —? |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Feb 27 | M | 5,921 | $0.00 | — |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Feb 13 | S | 6,958 | $310.08 | $2.2M |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Feb 12 | A | 14,209 | $0.00 | — |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 94 | $377.82 | $36K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 118 | $375.65 | $44K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 88 | $374.44 | $33K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 21 | $372.46 | $8K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 118 | $370.87 | $44K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 253 | $369.48 | $93K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 584 | $368.62 | $215K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 261 | $367.40 | $96K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 316 | $366.41 | $116K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 1,395 | $365.56 | $510K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 1,259 | $364.83 | $459K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 301 | $363.55 | $109K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 464 | $362.38 | $168K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 624 | $361.45 | $226K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 980 | $360.22 | $353K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 537 | $359.14 | $193K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 778 | $358.18 | $279K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 607 | $357.17 | $217K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 263 | $356.09 | $94K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 269 | $355.16 | $96K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 12 | S | 247 | $353.95 | $87K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Jan 11 | A | 19,003 | $0.00 | — |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEODERIV | Nov 26 | M | 659 | $0.00 | —? |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEODERIV | Nov 26 | M | 839 | $0.00 | —? |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEODERIV | Nov 26 | M | 847 | $0.00 | —? |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEODERIV | Nov 26 | M | 2,352 | $0.00 | —? |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 26 | F | 1,121 | $445.12 | $499K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 26 | M | 659 | $151.59 | $100K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 26 | M | 847 | $118.05 | $100K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 26 | M | 2,352 | $85.00 | $200K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 26 | M | 839 | $119.13 | $100K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEODERIV | Nov 13 | MPLAN | 10,000 | $0.00 | —? |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEODERIV | Nov 12 | MPLAN | 15,000 | $0.00 | —? |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEODERIV | Nov 12 | MPLAN | 650 | $0.00 | —? |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 13 | SPLAN | 261 | $456.03 | $119K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 13 | SPLAN | 195 | $454.69 | $89K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 13 | SPLAN | 881 | $453.99 | $400K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 13 | SPLAN | 1,599 | $452.85 | $724K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 13 | SPLAN | 1,702 | $451.94 | $769K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 13 | SPLAN | 2,218 | $450.69 | $1000K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 13 | SPLAN | 1,477 | $450.02 | $665K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 13 | SPLAN | 1,013 | $448.76 | $455K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 13 | SPLAN | 654 | $447.73 | $293K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 13 | MPLAN | 10,000 | $119.13 | $1.2M |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 12 | SPLAN | 430 | $458.42 | $197K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 12 | SPLAN | 604 | $457.71 | $276K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 12 | SPLAN | 2,420 | $456.64 | $1.1M |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 12 | SPLAN | 3,406 | $455.56 | $1.6M |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 12 | SPLAN | 1,960 | $454.84 | $891K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 12 | SPLAN | 1,069 | $453.52 | $485K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 12 | SPLAN | 1,210 | $452.43 | $547K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 12 | SPLAN | 1,255 | $451.16 | $566K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 12 | SPLAN | 453 | $450.17 | $204K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 12 | SPLAN | 2,132 | $449.15 | $958K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 12 | SPLAN | 711 | $448.07 | $319K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 12 | MPLAN | 15,000 | $119.13 | $1.8M |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Yvonne GreenstreetCEO | Nov 12 | MPLAN | 650 | $42.22 | $27K |